Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4OTG

Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib

Summary for 4OTG
Entry DOI10.2210/pdb4otg/pdb
Related4OTD 4OTH 4OTI
DescriptorSerine/threonine-protein kinase N1, Lestaurtinib (3 entities in total)
Functional Keywordsprk1, pkn1, protein kinase c related kinase 1, kinase, protein kinase, atp binding, phosphorylation, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm : Q16512
Total number of polymer chains1
Total formula weight38780.97
Authors
Chamberlain, P.P.,Delker, S.,Pagarigan, B.,Mahmoudi, A.,Jackson, P.,Abbassian, M.,Muir, J.,Raheja, N.,Cathers, B. (deposition date: 2014-02-13, release date: 2014-08-27, Last modification date: 2022-12-07)
Primary citationChamberlain, P.,Delker, S.,Pagarigan, B.,Mahmoudi, A.,Jackson, P.,Abbasian, M.,Muir, J.,Raheja, N.,Cathers, B.
Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes.
Plos One, 9:e103638-e103638, 2014
Cited by
PubMed Abstract: Protein kinase C related kinase 1 (PRK1) is a component of Rho-GTPase, androgen receptor, histone demethylase and histone deacetylase signaling pathways implicated in prostate and ovarian cancer. Herein we describe the crystal structure of PRK1 in apo form, and also in complex with a panel of literature inhibitors including the clinical candidates lestaurtinib and tofacitinib, as well as the staurosporine analog Ro-31-8220. PRK1 is a member of the AGC-kinase class, and as such exhibits the characteristic regulatory sequence at the C-terminus of the catalytic domain--the 'C-tail'. The C-tail fully encircles the catalytic domain placing a phenylalanine in the ATP-binding site. Our inhibitor structures include examples of molecules which both interact with, and displace the C-tail from the active site. This information may assist in the design of inhibitors targeting both PRK and other members of the AGC kinase family.
PubMed: 25111382
DOI: 10.1371/journal.pone.0103638
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

227344

数据于2024-11-13公开中

PDB statisticsPDBj update infoContact PDBjnumon